ABBV

Better Long-Term Buy: This Emerging Player or the Industry Leader?

01/30 04:30 pm

Novo Nordisk Outspends Eli Lilly On Wegovy, Ozempic Ads After Supply Crunch Eases

01/30 01:57 pm

Atopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR

01/27 11:00 am

Why Revolution Medicines Stock Plummeted by Almost 17% Today

01/26 08:16 pm

Revolution Medicines Stock Sinks After Merck Deal Talks Collapse

01/26 07:01 am

Corticosteroids Market Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

01/26 05:51 am

Johnson & Johnson Clears the Patent Cliff as 2026 Guidance Resets the Narrative

01/21 10:43 am

Bioconjugation Market Size to Hit USD 14.51 Billion by 2033, Driven by the Increasing Demand for Targeted Therapeutics – SNS Insider

01/19 12:00 pm

Could Buying This Stock Today Pay Off Big Over the Next 5 Years?

01/18 08:20 am

Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

01/16 02:30 pm

Actionable Insights in the Dermatology Market: Navigating Technological Advances and Growth Trends

01/16 05:56 am

Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight

01/13 02:00 pm

AbbVie Gets Tariff Relief, Pledges $100 Billion, Lower Prices For Key Medicines

01/13 09:09 am

Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight

01/09 02:52 am

Why Revolution Medicines Shares Are Sliding After Hours On Wednesday

01/08 04:13 am

Red Spruce Capital Nets $3.7 Million by Dumping One-Third of BSCR Shares

01/07 08:05 am

Buying This Healthcare Stock Could Make You a Millionaire Retiree

01/03 07:08 am

Ironwood Finds a New Floor as LINZESS Net Pricing Turns Into a Growth Lever

01/02 02:30 pm

3 No-Brainer Dividend Stocks to Buy Right Now

12/30 04:05 pm

Is AbbVie a Buy, Sell, or Hold in 2026?

12/27 03:30 pm

3 Dividend Growth Stocks Analysts Are Upgrading for 2026

12/22 10:24 am

White House Readies Drug Price Deals With AbbVie, Novartis, Roche

12/18 11:14 am

Want Decades of Passive Income? Buy This ETF and Hold It Forever.

12/17 03:11 pm

Want Decades of Passive Income? Buy This Index Fund and Hold It Forever.

12/14 06:15 am

Women’s Healthcare Market Worth USD 46.76 Billion by 2033 Driven by Rising Demand for Reproductive, Preventive, and Digital Health Solutions – SNS Insider

12/13 09:10 pm

Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026

12/12 01:23 pm

Dividend Powerhouses: 3 Blue-Chip Stocks Built for the Long Haul

12/12 12:10 pm

Is AbbVie Stock Too Cheap to Ignore at Today's Price?

12/11 12:06 pm

DISCO Pharmaceuticals Appoints Mark Manfredi as CEO and Announces Final Close of €36 Million Seed Financing

12/11 06:00 am

Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT)

12/08 05:30 pm

OSE Immunotherapeutics annonce un amendement stratégique au partenariat avec AbbVie sur le développement d’ABBV-230

12/08 02:30 am

OSE Immunotherapeutics Announces Strategic Amendment to AbbVie’s Partnership on ABBV-230 Development

12/08 02:30 am

Ophthalmic Drugs Market Size to Cross USD 62.74 Billion by 2032, Driven by Advances in Eye Care Treatments and Rising Global Vision Disorders - SNS Insider

12/07 09:05 am

Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2) in Patients with Relapsed or Refractory Follicular Lymphoma

12/07 08:50 am

Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)

12/06 10:30 am

3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026

12/04 07:15 am

ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors

12/02 10:00 am

AbbVie Scores Canadian Reimbursement Recommendations For Blockbuster Ulcerative Colitis Drug Skyrizi

11/28 11:50 am

Atopic Dermatitis Drugs Market to Reach $29.43 Billion by 2032, Driven by Rising Disease Prevalence & Strong Therapeutic Innovation | SNS Insider

11/28 01:28 am

5 Dividend Stocks to Hold for the Next 10 Years

11/24 08:25 am

Why Johnson & Johnson's Share Price Is Popping This Month

11/19 01:24 pm

Healthcare Rotation Underway: 3 Stocks Leading the Charge

11/19 10:37 am

AbbVie Stock Falls 4% -- What Investors Need to Know

11/17 08:17 am

This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000?

11/17 06:25 am

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.

11/15 08:25 am

Is the Schwab U.S. Dividend Equity ETF the "Ultimate Retirement Fund" for Investors?

11/13 05:08 am

NEXGEL (NXGL) Q3 2025 Earnings Call Transcript

11/11 06:05 pm

What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill.

11/09 12:05 pm

Got $5,000? These Are 3 of the Cheapest Growth Stocks to Buy Right Now

11/09 05:21 am

Is the Schwab U.S. Dividend Equity ETF a Buy Now?

11/08 09:31 am